Critical evaluation of the off-label indication and of the risks associated to the use of multi-dose vials on the treatment of age-related macular degeneration . (2014). Brazilian Journal of Pharmaceutical Sciences, 50(1), 63-72. https://doi.org/10.1590/S1984-82502011000100006